Pure open versus robotic radical cystectomy with intracorporeal urinary diversion: a propensity matched analysis
- PMID: 39630251
- DOI: 10.1007/s00345-024-05371-w
Pure open versus robotic radical cystectomy with intracorporeal urinary diversion: a propensity matched analysis
Abstract
Objective: To compare surgical parameters and short-term outcomes between open radical cystectomy (ORC) and robotic radical cystectomy with total intracorporeal urinary diversion (icRARC).
Methods: Among the study period, 133 patients who underwent ORC and pelvic node dissection for bladder cancer (group 1) were matched and compared to 61 patients who underwent icRARC during the same period (group 2). The groups were matched 1:1 according to their propensity scores adjusted on their baseline demographics and disease characteristics. The main surgical parameters compared were: operative time, estimated blood loss (EBL), and postoperative outcomes including time to oral intake, ninety-day complications, readmission rate, and secondary procedures.
Results: Overall, 122 patients (61 in each group) were matched and finally analyzed. Although operative times (307 ± 97 min vs. 444 ± 113 min; p < 0.001) were longer, EBL (948 ± 657 ml vs. 357 ± 219 ml; p < 0.001) and transfusion rates were lower in the icRARC group. Overall complications were comparable but late complications tended to be lower in the icRARC group (p = 0.06). Readmission rate (54.8% vs. 26.8%, p = 0.01) was higher in the ORC group while secondary procedures (28.6% vs. 12.5%, p = 0.07) also tended to be lower in the robotic approach. Finally, in multivariable logistic regression the icRARC group was not associated with any complications of any grade including grade 3 or higher compared to the open approach.
Conclusion: This study comparing open radical cystectomy to robotic radical cystectomy with total intracorporeal urinary diversion demonstrated encouraging outcomes for the minimally invasive management of urothelial carcinoma.
Keywords: Bladder cancer; Cystectomy; Ileal conduit; Ileal neobladder; Laparoscopy; Robotics; Urinary diversion.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Informed consent: For this study, oral consent was obtained for every patient. Competing interests: The authors declare no competing interests.
References
-
- Alfred Witjes J, Max Bruins H, Carrión A, Cathomas R, Compérat E, Efstathiou JA et al (2024) European Association of Urology Guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2023 guidelines. Eur Urol 85(1):17–31 - DOI
-
- Hedgepeth RC, Gilbert SM, He C, Lee CT, Wood DP (2010) Body image and bladder cancer specific quality of life in patients with ileal conduit and neobladder urinary diversions. Urol 76(3):671–675 - DOI
-
- Parekh DJ, Reis IM, Castle EP, Gonzalgo ML, Woods ME, Svatek RS et al (2018) Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial. Lancet 391(10139):2525–2536 - DOI
-
- Khan MS, Gan C, Ahmed K, Ismail AF, Watkins J, Summers JA et al (2016) A single-centre early phase randomised controlled three-arm trial of open, robotic, and laparoscopic radical cystectomy (CORAL). Eur Urol 69(4):613–621 - DOI
-
- Parra RO, Andrus CH, Jones JP, Boullier JA (1992) Laparoscopic cystectomy: initial report on a new treatment for the retained bladder. J Urol 148(4):1140–1144 - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical